Sexual and reproductive health

Combined hormonal contraceptive use during the postpartum period

Statement

Share

Authors:
UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)

Image of document

Publication details

Number of pages: 4
Publication date: 2010
Languages: English
WHO reference number: WHO/RHR/10.15 - Web only

Downloads

The identification of new evidence regarding the risk of venous thromboembolism (VTE) in postpartum women (not associated with combined hormonal contraceptives (CHC) use) indicated the need to evaluate this recommendation. A technical consultation was convened by WHO via teleconference on 26 January 2010. The consultation brought together international family planning experts, including clinicians, epidemiologists, haematologists, and perinatologists. The consultation focused on the risk of developing VTE during the postpartum period, and the theoretical additional risk that use of CHCs could pose.